Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10 December 2025 Contact:CFO, Per Bjarne Lyngstad, +47 952 44 515 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.
Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...
Borregaard ASA: Invitation to Q3 2025 announcement 15 October 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q3 2025 results Borregaard will report third quarter 2025 results on Wednesday 22 October 2025 at 07:00 CEST. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on . A presentation of the third quarter 2025 results will also be held at 08:30 CEST at ABG Sundal Collier, Ruseløkkveien 26, 8th floor, Oslo. Attendance in person is possible. The presentation can be followed live on web-TV at ...
Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013683730 of NOK 100,000,000. Start date: 14 October, 2025Maturity: 12 December, 2025Coupon: 4,20 %Organised by: DNB Markets Sarpsborg, 10 October 2025 Contact:Chief Financial Officer, Per Bjarne Lyngstad, This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Borregaard ASA: Borregaard to participate in a convertible loan to Alginor Borregaard, together with the shareholders Must Invest and Hatteland Group, will act as guarantors for a NOK 200 million convertible loan to Alginor. The loan may be converted to new shares by the lenders. The subscription price upon exercise of the conversion right shall be NOK 10 per share, subject to adjustment for corporate actions such as share splits, reversed splits, dividends etc. All shareholders in Alginor will be invited to participate in the convertible loan. Depending on the shareholder participation, ...
Borregaard ASA: NOK 15 million grant for Borregaard’s Biomer project The Norwegian Research Council (NFR) has awarded NOK 15 million to support Borregaard’s innovation initiative, Biomer. The project aims to develop bio-based alternatives to polycarboxylates – fossil-based polymers commonly used in agriculture, industry, and household products. Polycarboxylates are known for their persistence in the environment and high carbon footprint. Through Biomer, Borregaard will develop new ways to turn Norwegian bioresources into greener polymers designed to replace these fossil-based materials. T...
Borregaard ASA: Temporary disruption in production of speciality cellulose Borregaard has experienced an unforeseen outage at a facility at the Sarpsborg site, which supplies a key chemical used in the production of speciality cellulose. During the period of the outage, cellulose production was restricted to grades outside standard specifications, resulting in delays of shipments of certain speciality cellulose grades. Production of other products at the biorefinery – including lignin-based biopolymers, bio-vanillin, bioethanol, and cellulose fibrils – remained unaffected. Borregaard has ...
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five years (1 August 2030) and may be exercised in the last two years. The strike price of the options is NOK 219.31, based on the volume-weighted average share price (VWAP) over the last three trading days in July 2025 (29, 30 and 31 July), plus a 10% premium. The strike price wil...
Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three R&D centres, and thirteen sales offices in key markets across Europe, the Americas, and Asia. We will continue to build on this solid foundation and our highly skilled organisation to advance our strategy of specialisation and value growth. Borregaard will continue to build on a strong legacy of specialisati...
Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for b...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.